Skip to content
Assyro AI
Assyro eCTD

Supplemental New Drug Submission (SNDS), Health Canada eCTD

Build supplements in the product's existing eCTD lifecycle and validate every sequence before you file. For sponsors filing in-house and consultancies filing for clients.

SNDS Filing Workflow

See where supplements lose time across drafting, review, validation, and readiness.

  • Write the Canadian Module 1 for Each SNDS Sequence

    Assyro writes ca-regional.xml to Health Canada's Module 1 schema 2.2 with the SNDS regulatory activity type.

  • Stop Schema Errors Before the Build

    A Module 1 that does not match the Canadian schema is stopped before the sequence is built.

  • Validate Against Health Canada's Rules

    Each sequence is checked against Health Canada's eCTD validation rules, version 5.3.

  • Keep the Lifecycle in Order

    Each sequence records the sequence it relates to, so the dossier's history stays readable.

SNDS Filing Controls and Capacity

Keep submission growth controlled with clearer ownership, better traceability, and consistent execution across active programs.

  • Maintain Audit-Ready SNDS Records

    Supplement sequences are checked against Health Canada's Module 1 schema 2.2 and eCTD validation rules version 5.3, with audit trails and role-based access.

  • Manage More SNDS Programs With the Same Team Size

    Track Health Canada correspondence and commitments in Assyro RIM

Questions About SNDS Submission Software

Practical questions sponsors and consultancies ask about Health Canada supplements.

Agent CTA Background

See Your Next Supplement in Assyro.